Literature DB >> 8285646

Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin.

C A Day1, M L Marceau-Day, D F Day.   

Abstract

Vancomycin in combination with ciprofloxacin exhibited synergy against 7 of 10 strains of Pseudomonas aeruginosa. MICs for the microbial strains used in this study ranged from 0.0325 to 3.0 micrograms/ml for ciprofloxacin and from 23.5 to > 188 micrograms/ml for vancomycin. Combinations of these antibiotics, tested in a checkerboard pattern, gave fractional inhibitory concentrations of 0.5 or less for 7 of the 10 strains tested.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8285646      PMCID： PMC192421          DOI： 10.1128/AAC.37.11.2506

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  The crisis in antibiotic resistance.

Authors:  H C Neu
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

2.  Investigations into the mechanism of action of the antibacterial agent norfloxacin.

Authors:  G C Crumplin; M Kenwright; T Hirst
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

Review 3.  DNA topoisomerases.

Authors:  M Gellert
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

4.  Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.

Authors:  P Van der Auwera; P Joly
Journal:  J Antimicrob Chemother       Date:  1987-03       Impact factor: 5.790

5.  Endogenous active efflux of norfloxacin in susceptible Escherichia coli.

Authors:  S P Cohen; D C Hooper; J S Wolfson; K S Souza; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

6.  Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.

Authors:  D C Hooper; J S Wolfson; K S Souza; C Tung; G L McHugh; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

7.  Mechanism of action of nalidixic acid on Escherichia coli. 3. Conditions required for lethality.

Authors:  W H Deitz; T M Cook; W A Goss
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

8.  Bactericidal activity and killing rate of serum in volunteers receiving ciprofloxacin alone or in combination with vancomycin.

Authors:  P Van der Auwera; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

9.  Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.

Authors:  N X Chin; K Jules; H C Neu
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

10.  A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients.

Authors:  G M Smith; M J Leyland; I D Farrell; A M Geddes
Journal:  J Antimicrob Chemother       Date:  1988-05       Impact factor: 5.790
View more
  7 in total

1.  Local release of antibiotics for surgical site infection management using high-purity calcium sulfate: an in vitro elution study.

Authors:  Sean S Aiken; John J Cooper; Hannah Florance; Matthew T Robinson; Stephen Michell
Journal:  Surg Infect (Larchmt)       Date:  2014-08-22       Impact factor: 2.150

2.  Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa.

Authors:  P Plesiat; J R Aires; C Godard; T Köhler
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

3.  nBioChip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream Applications.

Authors:  Anand Srinivasan; Nelson S Torres; Kai P Leung; Jose L Lopez-Ribot; Anand K Ramasubramanian
Journal:  mSphere       Date:  2017-06-28       Impact factor: 4.389

4.  A Genetic Screen Reveals Novel Targets to Render Pseudomonas aeruginosa Sensitive to Lysozyme and Cell Wall-Targeting Antibiotics.

Authors:  Kang-Mu Lee; Keehoon Lee; Junhyeok Go; In Ho Park; Jeon-Soo Shin; Jae Young Choi; Hyun Jik Kim; Sang Sun Yoon
Journal:  Front Cell Infect Microbiol       Date:  2017-03-01       Impact factor: 5.293

5.  Non-invasive, ratiometric determination of intracellular pH in Pseudomonas species using a novel genetically encoded indicator.

Authors:  Alejandro Arce-Rodríguez; Daniel C Volke; Sarina Bense; Susanne Häussler; Pablo I Nikel
Journal:  Microb Biotechnol       Date:  2019-06-04       Impact factor: 5.813

6.  Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas aeruginosa.

Authors:  Imran Mohammed; Dalia G Said; Mario Nubile; Leonardo Mastropasqua; Harminder S Dua
Journal:  Front Microbiol       Date:  2019-09-19       Impact factor: 5.640

7.  Increasing the permeability of Escherichia coli using MAC13243.

Authors:  Claudio Muheim; Hansjörg Götzke; Anna U Eriksson; Stina Lindberg; Ida Lauritsen; Morten H H Nørholm; Daniel O Daley
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.